Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03299569 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland

Study acronym: STARR
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since Mar 19, 2025, no change to tracked fieldsv7-v8
  2. Primary endpoint revised
    • Secondary endpoint revised
    v6
  3. Primary endpoint revised
    • Secondary endpoints expanded, about 9 words
    v5
  4. Primary and study completion dates: Dec 31, 2023 to Dec 31, 2028v4
  5. Study description shortened, about 38 wordsv3
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Acute stress-induced (Takotsubo cardiomyopathy) presents like a heart attack and is triggered by intense emotional or physical stress. Although coronary arteries are unobstructed, it has been suggested that the risk of death is similar to a myocardial infarction. The purpose of the STARR study is to identify all cases of Takotsubo in Scotland since 2010 and assess its epidemiology and outcomes.
Trial Details
NCT Number NCT03299569
Lead Sponsor University of Aberdeen
Collaborators: NHS Tayside, NHS Lothian, NHS Highlands, NHS Ayrshire and Arran, Golden Jubilee National Hospital, NHS Greater Glasgow and Clyde, NHS Lanarkshire
Conditions
(from sponsor)		 Takotsubo Cardiomyopathy, Myocardial Infarction
Related terms Myocardial Infarction, Takotsubo Cardiomyopathy
Enrollment 800 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov